An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli - Test2 - elhamkhani - TriplyDB

An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli

An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli

http://www.wikidata.org/entity/Q28750246

about

sameAs

The Receptor-Binding Domain of Influenza Virus Hemagglutinin Produced in Escherichia coli Folds into Its Native, Immunogenic Structure Acid Stability of the Hemagglutinin Protein Regulates H5N1 Influenza Virus Pathogenicity Antibody Recognition of the Pandemic H1N1 Influenza Virus Hemagglutinin Receptor Binding Site Emerging influenza viruses and the prospect of a universal influenza virus vaccine.Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets.A novel hemagglutinin protein produced in bacteria protects chickens against H5N1 highly pathogenic avian influenza viruses by inducing H5 subtype-specific neutralizing antibodies Vaccination with Killed but Metabolically Active E. coli Over-expressing Hemagglutinin Elicits Neutralizing Antibodies to H1N1 Swine Origin Influenza A Virus Cell-free production of trimeric influenza hemagglutinin head domain proteins as vaccine antigens.Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice Sublingual administration of bacteria-expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virus.A baseline process for the production, recovery, and purification of bacterial influenza vaccine candidates.Seroprevalence of antibodies to influenza A/H1N1/2009 among transmission risk groups after the second wave in Mexico, by a virus-free ELISA method.Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein.Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines.Characterization of Influenza Vaccine Hemagglutinin Complexes by Cryo-Electron Microscopy and Image Analyses Reveals Structural Polymorphisms Rescuing recombinant proteins by sequestration into the P22 VLP Retrospective serology study of respiratory virus infections in captive great apes.Immunity toward H1N1 influenza hemagglutinin of historical and contemporary strains suggests protection and vaccine failure.A Systematic Protein Refolding Screen Method using the DGR Approach Reveals that Time and Secondary TSA are Essential Variables.Harnessing an RNA-mediated chaperone for the assembly of influenza hemagglutinin in an immunologically relevant conformation.

P2860

Q27665742-58B801B1-0DC3-4A53-AF16-0B3CE4EFB424 Q27676000-1B8B2F21-7F97-46A3-B15C-9A632C61B4F0 Q27679927-0F4C9D7A-0DDC-4E7A-82C2-0829CEA1E498 Q30372274-90585B3E-986F-4C2E-ACB7-C7F754773BCF Q30396343-83BD0B15-622C-4E89-8034-3C0CBE6177CB Q30398811-1B46825A-3B67-46B8-BAFA-4FA1F205C956 Q30401849-A6FE59D6-EF54-4AC7-A0DF-DACC7650ED29 Q30418486-08472D24-65ED-476F-9F77-D6544B34FC53 Q30425194-5CFD4488-BD96-49C9-8FF2-20633B47F6A9 Q30427778-A0BE7BEE-5B60-480F-A143-87F3A931A67A Q30431659-0485801A-659B-4CA4-824D-7A63C1AF7869 Q33698250-C0A653CF-1D73-4E00-8D87-544EFECFD6BB Q35816320-0FE8BE1A-C034-4F3D-99BE-4CC613C4DE73 Q36779713-8073120C-C1D7-403C-AF43-07FAE1F5C484 Q36973969-D4446E8F-ADD5-48C9-A6CE-A96FE46BEDF4 Q37438919-72478902-9481-4898-A619-F6A46FFFACCA Q37673169-DF98C806-7B95-4E1D-AC40-A378DF591950 Q39431643-3119F883-4BD8-4E29-B3DD-DF282DBAA2DF Q41516588-3D79A79F-11A7-43AF-8710-12ABF7ECB10B Q47236983-576BD3EF-4A32-4BB5-A6EB-2BC2E8F6BA97

P2860

An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli

http://www.wikidata.org/entity/Q28750246

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli

@ast

An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli

@en

An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli

@nl

type

label

An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli

@ast

An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli

@en

An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli

@nl

prefLabel

An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli

@ast

An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli

@en

An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli

@nl

P1433

Q28750246-73694EC6-24E3-4E56-9417-4E72CC7411C0

P1476

Q28750246-2237B630-9CED-4819-9249-9A5EAB46428C

P2093

Q28750246-120074E0-40CE-450C-A827-7225FF4E5D71

Q28750246-454067B9-A3B1-4D81-860D-ED9E92F88D32

Q28750246-4BC5DBE8-21BF-437A-B92F-FF8858CB341D

Q28750246-6D8C0755-8FF9-4D33-B9FB-9E34F5C4066D

Q28750246-834C68A4-AFDC-4F08-9568-75AA07D7F449

Q28750246-A7CC23E6-97F4-4E5E-BD65-5CD494BBC799

Q28750246-A843FD24-FE6C-4D3D-9017-0A14A1E47BD0

Q28750246-A9CECFDF-1465-46AC-A5AB-32F5055F0BF3

Q28750246-AD46AADD-246E-4890-8DC3-5675DB9F637B

Q28750246-CE60E15A-4A64-47FD-BBF3-24566F6D9513

P2860

Q28750246-052EBF74-BF05-43EC-B5FF-3183698AAF8D

Q28750246-07E31D58-24FA-4CBF-BECE-302ABD0C9292

Q28750246-0A0016C3-6542-4BDD-905C-7BB11D165FD1

Q28750246-0AADBD32-7BEB-444D-A4AF-C522F386F0B4

Q28750246-0E17F5DE-F97B-4125-A9FC-EA3C7A6CA932

Q28750246-0ED9ABB1-4E6C-4E50-93E0-45A3ED861A06

Q28750246-12A97378-F25F-4473-B0A6-CEC6E3CCC284

Q28750246-17E07E36-C910-4621-A163-3624DF792ABF

Q28750246-19E054EA-BBAC-481B-AF47-95FF0E38757C

Q28750246-30E5D2F5-FE42-4956-BB13-D3A5F890010E

P304

Q28750246-E42CCE8E-87A2-4009-97CE-888A32AE64B1

P31

Q28750246-2B6733F4-B16E-4486-84C1-51AA8F5722B3

P3181

Q28750246-4002E385-BE22-44EC-A877-587B1B28ABE4

P356

Q28750246-0C36E28D-9D22-4B9E-81D1-E2DCFBA895CE

P407

Q28750246-AF1BF758-38D9-4FE2-BD18-57B5E2BE0725

P433

Q28750246-2E519DC8-7E33-4ADA-B698-4AF287524B84

P478

Q28750246-6977759B-019E-490B-98D1-5341BBFFC189

P50

Q28750246-0DD13B7D-193F-4EB4-81A6-BBA31C250B3C

Q28750246-3526997A-C50F-4CB4-99DD-9E0499221BF6

Q28750246-68DB0C66-A50B-4EFB-A687-A1C4465C3C67

Q28750246-97489578-0E99-4CC1-83DF-FC99DF9B996B

Q28750246-F35D407E-11A4-496A-8CAF-33EA99538800

P577

Q28750246-A41170C5-108B-4019-89DC-7BA93AFDC5C0

P5875

Q28750246-F54895A8-A1FA-4B7A-B746-1941A97DE663

P698

Q28750246-56EB4822-41E4-4E52-A52A-041B1363903C

P932

Q28750246-EF49E9E1-8FFA-4205-9402-EC79F7EF1B6C

P3181

P356

JOURNAL.PONE.0011694

P1433

P1476

An influenza A/H1N1/2009 hemagglutinin vaccine produced in Escherichia coli

@en

P2093

Charles J Russell

http://www.w3.org/2001/XMLSchema#string

David Bulnes-Abundis

http://www.w3.org/2001/XMLSchema#string

Felipe López-Pacheco

http://www.w3.org/2001/XMLSchema#string

Felipe O León-Angel

http://www.w3.org/2001/XMLSchema#string

Gonzalo I Mendoza-Ochoa

http://www.w3.org/2001/XMLSchema#string

Guillermo M Ruiz-Palacios

http://www.w3.org/2001/XMLSchema#string

Itzel M Lara-Mayorga

http://www.w3.org/2001/XMLSchema#string

Johari Salgado-Gallegos

http://www.w3.org/2001/XMLSchema#string

Manuel I Zertuche-Guerra

http://www.w3.org/2001/XMLSchema#string

Ramón E Rivero-Aranda

http://www.w3.org/2001/XMLSchema#string

P2860

Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin

Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus

Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus

Size-Distribution Analysis of Macromolecules by Sedimentation Velocity Ultracentrifugation and Lamm Equation Modeling

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

Solubilization and refolding of bacterial inclusion body proteins

Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection

Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels

Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems

The structure and function of the hemagglutinin membrane glycoprotein of influenza virus

P304

e11694

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2335421

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0011694

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Mario Moisés Alvarez

Rebecca M DuBois

Yuriana Oropeza-Almazán

Sergio A García-Echauri

José M Aguilar-Yáñez

P577

2010-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45367081

http://www.w3.org/2001/XMLSchema#string

P698

20661476

http://www.w3.org/2001/XMLSchema#string

P932

2908544

http://www.w3.org/2001/XMLSchema#string